Legacy Trust Albemarle Corp Transaction History

Legacy Trust

$507 Billion
Q3 2025

A detailed history of Legacy Trust transactions in Albemarle Corp stock. As of the latest transaction made, Legacy Trust holds 23,979 shares of ALB stock, worth $2.76 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

23,979

Previous 26,052 7.96%

Holding current value

$2.76 Million

Previous $1.63 Billion 19.08%

% of portfolio

0.38%

Previous 0.4%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 24, 2025	SELL	$62.9 - $88.1 $130,391 - $182,631	-2,073 Reduced 7.96%	23,979 $1.94 Billion
Q2 2025 Jul 22, 2025	SELL	$50.76 - $72.25 $808,302 - $1.15 Million	-15,924 Reduced 37.94%	26,052 $1.63 Billion
Q1 2025 Apr 16, 2025	BUY	$69.95 - $97.49 $95,971 - $133,756	1,372 Added 3.38%	41,976 $3.02 Billion
Q4 2024 Jan 23, 2025	SELL	$86.08 - $111.3 $67,314 - $87,036	-782 Reduced 1.89%	40,604 $3.5 Billion
Q3 2024 Oct 29, 2024	BUY	$72.85 - $100.09 $314,566 - $432,188	4,318 Added 11.65%	41,386 $3.92 Billion

Q2 2024 Jul 16, 2024	BUY	$92.77 - $135.46 $209,103 - $305,326	2,254 Added 6.47%	37,068 $3.54 Billion
Q1 2024 Apr 23, 2024	BUY	$108.73 - $146.89 $166,356 - $224,741	1,530 Added 4.6%	34,814 $4.59 Billion
Q4 2023 Jan 24, 2024	BUY	$113.26 - $170.8 $120,848 - $182,243	1,067 Added 3.31%	33,284 $4.81 Billion
Q3 2023 Oct 16, 2023	BUY	$162.63 - $243.44 $50,090 - $74,979	308 Added 0.97%	32,217 $5.48 Billion
Q2 2023 Aug 08, 2023	BUY	$172.91 - $232.22 $53,256 - $71,523	308 Added 0.97%	31,909 $7.12 Billion
Q1 2023 Apr 19, 2023	SELL	$208.49 - $290.15 $6,254 - $8,704	-30 Reduced 0.09%	31,601 $6.99 Billion
Q4 2022 Apr 03, 2023	BUY	$214.02 - $325.38 $6.77 Million - $10.3 Million	31,631 New	31,631 $6.86 Billion

Others Institutions Holding ALB

# of Institutions

931

Shares Held

111M

Call Options Held

10.4M

Put Options Held

15.1M

View Full List

About ALBEMARLE CORP

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $13.5B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

More about ALB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Trust, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Trust with notifications on news.

Account